Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-25-028452

President & Immunovant CEO acquired 198,413 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & Immunovant CEO 2025-07-30 Grant or award +198,413 1,660,636 D
Loading xslF345X05/form4.xml…